How has been the historical performance of MPS Pharmaa?

Answer:The historical performance of MPS Pharmaa shows a declining trend in key financial metrics over the years, particularly from 2018 to 2025.

Breakdown:
MPS Pharmaa's net sales peaked at 4.00 Cr in March 2018 but have since declined to 0.00 Cr by March 2025. Other operating income also saw a decrease, dropping from 0.10 Cr in March 2018 to 0.00 Cr in March 2025. Total operating income followed a similar trend, falling from 4.09 Cr in March 2018 to 0.00 Cr in March 2025. The company's total expenditure, excluding depreciation, was highest in March 2017 at 9.72 Cr and has since decreased to 0.76 Cr in March 2025. Operating profit (PBDIT) has remained negative throughout this period, with the most significant loss recorded in March 2017 at -6.88 Cr, improving slightly to -0.71 Cr by March 2025. Profit before tax and profit after tax also reflect losses, with the latter reaching -0.90 Cr in March 2025. The company's total liabilities decreased from 16.41 Cr in March 2020 to 9.33 Cr in March 2025, while total assets also declined from 16.41 Cr in March 2020 to 9.33 Cr in March 2025. The book value per share has decreased from 4.38 in March 2020 to 0.57 in March 2025, indicating a significant reduction in shareholder value. Overall, MPS Pharmaa's financial performance has deteriorated significantly over the years, with consistent losses and declining revenues.